EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Targeting mitochondrial stress with Szeto‐Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress

Miquel Navas-Madroñal, Rafael Almendra-Pegueros, Lidia Puertas-Umbert, Francesc Jiménez-Altayó, Josep Julve, Belén Pérez, Marta Consegal-Pérez, Modar Kassan, José Martínez-González, Cristina Rodriguez, María Galán iD

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16077 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Miquel Navas-Madroñal and 10 co-authors. Institution: Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain. Major MEDLINE topics: Aortic Aneurysm, Abdominal. Cited 19 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Instituto de Salud Carlos III.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Mitochondrial dysfunction and inflammation contribute to a myriad of cardiovascular diseases. Deleterious crosstalk of mitochondria and persistent endoplasmic reticulum (ER) stress triggers oxidative stress, which is involved in the development of vascular diseases. This study determined if inhibition of mitochondrial stress reduces aneurysm development in angiotensin II (Ang II)‐infused apolipoprotein‐E‐deficient (ApoE −/− ) mice and its effect on ER stress. Experimental Approach The mitochondria‐targeted tetrapeptide, Szeto‐Schiller 31 (SS31), ameliorated mitochondrial dysfunction and the enhanced expression of ER stress markers triggered by Ang II in ApoE −/− mice, and limited plasmatic and vascular reactive oxygen species (ROS) levels. Interestingly, SS31 improved survival, reduced the incidence and severity of abdominal aortic aneurysm (AAA), and the Ang II‐induced increase in aortic diameter as evaluated by ultrasonography, resembling the response triggered by the classic ER stress inhibitors tauroursodeoxycholic acid (TUDCA) and 4‐phenylbutyrate (PBA). Key Results Disorganization of the extracellular matrix, increased expression of metalloproteinases and pro‐inflammatory markers and infiltration of immune cells induced by Ang II in the abdominal aorta were effectively reduced by SS31 and ER inhibitors. Further, C/EBP homologous protein (CHOP) deficiency in ApoE −/− mice attenuated Ang II‐mediated increase in vascular diameter and incidence of AAA, suggesting its contribution to the favourable response induced by ER stress inhibition. Conclusions and Implications Our data demonstrate that inhibition of mitochondrial stress by SS31 limits AAA formation and increases survival through a reduction of vascular remodelling, inflammation and ROS, and support that attenuation of ER stress contributes to the favourable response elicited by SS31.

Subjects

MeSH terms (MEDLINE)

Aortic Aneurysm, AbdominalMiceAnimalsReactive Oxygen SpeciesAorta, AbdominalEndoplasmic Reticulum StressMitochondriaApolipoproteins EInflammationAngiotensin IIDisease Models, AnimalMice, Inbred C57BLMice, Knockout

Author keywords

ageingantioxidantshypertensionin vivoinflammationsmall moleculestranslational pharmacologyvascular pharmacology

Substances

Reactive Oxygen SpeciesApolipoproteins EAngiotensin II

Authors and institutions

  • Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Department of Pharmacology, Toxicology and Therapeutics, Neuroscience Institute, Faculty of Medicine, Universidad Autónoma de Barcelona, Bellaterra, Barcelona, Spain.
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • College of Dental Medicine, Lincoln Memorial University, Knoxville, Tennessee, 37917, USA.
  • Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), IIB Sant Pau, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.

ORCID profiles: María Galán

Funding

  • Instituto de Salud Carlos III

Cite

APA

Navas-Madroñal, M., Almendra-Pegueros, R., Puertas-Umbert, L., Jiménez-Altayó, F., Julve, J., Pérez, B., Consegal-Pérez, M., Kassan, M., Martínez-González, J., Rodriguez, C., & Galán, M. (2023). Targeting mitochondrial stress with Szeto‐Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress. British Journal of Pharmacology. https://doi.org/10.1111/bph.16077

Vancouver

Navas-Madroñal M, Almendra-Pegueros R, Puertas-Umbert L, Jiménez-Altayó F, Julve J, Pérez B, et al. Targeting mitochondrial stress with Szeto‐Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress. British Journal of Pharmacology. 2023. doi:10.1111/bph.16077

BibTeX
@article{NavasMadroal2023,
  author = {Navas-Madroñal, Miquel and Almendra-Pegueros, Rafael and Puertas-Umbert, Lidia and Jiménez-Altayó, Francesc and Julve, Josep and Pérez, Belén and Consegal-Pérez, Marta and Kassan, Modar and Martínez-González, José and Rodriguez, Cristina and Galán, María},
  title = {Targeting mitochondrial stress with Szeto‐Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16077}
}
Start for free →